Advertisement

Index by author

December 01, 1996; Volume 24,Issue 12

A

  1. Abbas, R R

    1. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.
      R R Abbas, C S Seckel, J K Kidney and J W Fisher
      Drug Metabolism and Disposition December 1996, 24 (12) 1340-1346;

  2. Aeschlimann, C

    1. Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.
      C Aeschlimann, T Cerny and A Küpfer
      Drug Metabolism and Disposition December 1996, 24 (12) 1336-1339;

  3. Akimoto, M

    1. Retention mechanism of imidazoles in connective tissue. I. Binding to elastin.
      K Ohta, J I Yamaguchi, M Akimoto, K Fukushima, T Suwa and S Awazu
      Drug Metabolism and Disposition December 1996, 24 (12) 1291-1297;

  4. Aksoy, I A

    1. Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation.
      C Her, C Szumlanski, I A Aksoy and R M Weinshilboum
      Drug Metabolism and Disposition December 1996, 24 (12) 1328-1335;

  5. Awazu, S

    1. Retention mechanism of imidazoles in connective tissue. I. Binding to elastin.
      K Ohta, J I Yamaguchi, M Akimoto, K Fukushima, T Suwa and S Awazu
      Drug Metabolism and Disposition December 1996, 24 (12) 1291-1297;

B

  1. Bajpai, M

    1. Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.
      M Bajpai, L K Roskos, D D Shen and R H Levy
      Drug Metabolism and Disposition December 1996, 24 (12) 1401-1403;

  2. Balani, S K

    1. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
      S K Balani, E J Woolf, V L Hoagland, M G Sturgill, P J Deutsch, K C Yeh and J H Lin
      Drug Metabolism and Disposition December 1996, 24 (12) 1389-1394;

  3. Bellevue, F H

    1. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
      D J Edwards, F H Bellevue and P M Woster
      Drug Metabolism and Disposition December 1996, 24 (12) 1287-1290;

  4. Bocker, R

    1. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines.
      W A Schmalix, D Lang, A Schneider, R Bocker, H Greim and J Doehmer
      Drug Metabolism and Disposition December 1996, 24 (12) 1314-1319;

C

  1. Carver, G

    1. Structural characteristics of flavin-containing monooxygenase genes one and two (FMO1 and FMO2).
      M K Wyatt, R M Philpot, G Carver, M P Lawton and K N Nikbakht
      Drug Metabolism and Disposition December 1996, 24 (12) 1320-1327;

  2. Cerny, T

    1. Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.
      C Aeschlimann, T Cerny and A Küpfer
      Drug Metabolism and Disposition December 1996, 24 (12) 1336-1339;

  3. Chapman, D E

    1. Catalysis of the dealkylation/debenzylation of phenoxazone ethers by hemoglobin in the absence of peroxides: implications for investigations of embryonic biotransformation.
      M R Juchau, D E Chapman, H Y Yang, Q P Lee, M J Namkung and T R Hinds
      Drug Metabolism and Disposition December 1996, 24 (12) 1362-1368;

  4. Chen, I W

    1. Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.
      J H Lin, M Chiba, I W Chen, J A Nishime and K J Vastag
      Drug Metabolism and Disposition December 1996, 24 (12) 1298-1306;

  5. Chiba, M

    1. Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.
      J H Lin, M Chiba, I W Chen, J A Nishime and K J Vastag
      Drug Metabolism and Disposition December 1996, 24 (12) 1298-1306;

  6. Ching, M S

    1. Conjugation of para-nitrophenol by isolated perfused fetal sheep liver.
      J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J Morgan
      Drug Metabolism and Disposition December 1996, 24 (12) 1378-1384;

  7. Chiu, S H

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

  8. Cioffe, C

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

  9. Colletti, A E

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

D

  1. Dean, D

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

  2. Deutsch, P J

    1. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
      S K Balani, E J Woolf, V L Hoagland, M G Sturgill, P J Deutsch, K C Yeh and J H Lin
      Drug Metabolism and Disposition December 1996, 24 (12) 1389-1394;

  3. Doehmer, J

    1. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines.
      W A Schmalix, D Lang, A Schneider, R Bocker, H Greim and J Doehmer
      Drug Metabolism and Disposition December 1996, 24 (12) 1314-1319;

E

  1. Edwards, D J

    1. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
      D J Edwards, F H Bellevue and P M Woster
      Drug Metabolism and Disposition December 1996, 24 (12) 1287-1290;

  2. Eisler, M C

    1. Pharmacokinetics of the chemoprophylactic and chemotherapeutic trypanocidal drug isometamidium chloride (Samorin) in cattle.
      M C Eisler
      Drug Metabolism and Disposition December 1996, 24 (12) 1355-1361;

F

  1. Fabris, D

    1. Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein P7.
      Y Hathout, D Fabris, M S Han, R C Sowder, L E Henderson and C Fenselau
      Drug Metabolism and Disposition December 1996, 24 (12) 1395-1400;

  2. Fekete, T

    1. Does hepatic ATP depletion impair glycine conjugation in vivo?
      Z Gregus, T Fekete, E Halászi and C D Klaassen
      Drug Metabolism and Disposition December 1996, 24 (12) 1347-1354;

  3. Fenselau, C

    1. Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein P7.
      Y Hathout, D Fabris, M S Han, R C Sowder, L E Henderson and C Fenselau
      Drug Metabolism and Disposition December 1996, 24 (12) 1395-1400;

  4. Fisher, J W

    1. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.
      R R Abbas, C S Seckel, J K Kidney and J W Fisher
      Drug Metabolism and Disposition December 1996, 24 (12) 1340-1346;

  5. Fukushima, K

    1. Retention mechanism of imidazoles in connective tissue. I. Binding to elastin.
      K Ohta, J I Yamaguchi, M Akimoto, K Fukushima, T Suwa and S Awazu
      Drug Metabolism and Disposition December 1996, 24 (12) 1291-1297;

G

  1. Ghabrial, H

    1. Conjugation of para-nitrophenol by isolated perfused fetal sheep liver.
      J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J Morgan
      Drug Metabolism and Disposition December 1996, 24 (12) 1378-1384;

  2. Gregus, Z

    1. Does hepatic ATP depletion impair glycine conjugation in vivo?
      Z Gregus, T Fekete, E Halászi and C D Klaassen
      Drug Metabolism and Disposition December 1996, 24 (12) 1347-1354;

  3. Greim, H

    1. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines.
      W A Schmalix, D Lang, A Schneider, R Bocker, H Greim and J Doehmer
      Drug Metabolism and Disposition December 1996, 24 (12) 1314-1319;

H

  1. Halászi, E

    1. Does hepatic ATP depletion impair glycine conjugation in vivo?
      Z Gregus, T Fekete, E Halászi and C D Klaassen
      Drug Metabolism and Disposition December 1996, 24 (12) 1347-1354;

  2. Han, M S

    1. Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein P7.
      Y Hathout, D Fabris, M S Han, R C Sowder, L E Henderson and C Fenselau
      Drug Metabolism and Disposition December 1996, 24 (12) 1395-1400;

  3. Hathout, Y

    1. Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein P7.
      Y Hathout, D Fabris, M S Han, R C Sowder, L E Henderson and C Fenselau
      Drug Metabolism and Disposition December 1996, 24 (12) 1395-1400;

  4. Henderson, L E

    1. Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein P7.
      Y Hathout, D Fabris, M S Han, R C Sowder, L E Henderson and C Fenselau
      Drug Metabolism and Disposition December 1996, 24 (12) 1395-1400;

  5. Her, C

    1. Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation.
      C Her, C Szumlanski, I A Aksoy and R M Weinshilboum
      Drug Metabolism and Disposition December 1996, 24 (12) 1328-1335;

  6. Hinds, T R

    1. Catalysis of the dealkylation/debenzylation of phenoxazone ethers by hemoglobin in the absence of peroxides: implications for investigations of embryonic biotransformation.
      M R Juchau, D E Chapman, H Y Yang, Q P Lee, M J Namkung and T R Hinds
      Drug Metabolism and Disposition December 1996, 24 (12) 1362-1368;

  7. Hoagland, V L

    1. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
      S K Balani, E J Woolf, V L Hoagland, M G Sturgill, P J Deutsch, K C Yeh and J H Lin
      Drug Metabolism and Disposition December 1996, 24 (12) 1389-1394;

J

  1. Juchau, M R

    1. Catalysis of the dealkylation/debenzylation of phenoxazone ethers by hemoglobin in the absence of peroxides: implications for investigations of embryonic biotransformation.
      M R Juchau, D E Chapman, H Y Yang, Q P Lee, M J Namkung and T R Hinds
      Drug Metabolism and Disposition December 1996, 24 (12) 1362-1368;

K

  1. Kidney, J K

    1. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.
      R R Abbas, C S Seckel, J K Kidney and J W Fisher
      Drug Metabolism and Disposition December 1996, 24 (12) 1340-1346;

  2. Klaassen, C D

    1. Does hepatic ATP depletion impair glycine conjugation in vivo?
      Z Gregus, T Fekete, E Halászi and C D Klaassen
      Drug Metabolism and Disposition December 1996, 24 (12) 1347-1354;

  3. Krieter, P A

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

  4. Küpfer, A

    1. Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.
      C Aeschlimann, T Cerny and A Küpfer
      Drug Metabolism and Disposition December 1996, 24 (12) 1336-1339;

L

  1. Lang, D

    1. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines.
      W A Schmalix, D Lang, A Schneider, R Bocker, H Greim and J Doehmer
      Drug Metabolism and Disposition December 1996, 24 (12) 1314-1319;

  2. Lawton, M P

    1. Structural characteristics of flavin-containing monooxygenase genes one and two (FMO1 and FMO2).
      M K Wyatt, R M Philpot, G Carver, M P Lawton and K N Nikbakht
      Drug Metabolism and Disposition December 1996, 24 (12) 1320-1327;

  3. Lee, Q P

    1. Catalysis of the dealkylation/debenzylation of phenoxazone ethers by hemoglobin in the absence of peroxides: implications for investigations of embryonic biotransformation.
      M R Juchau, D E Chapman, H Y Yang, Q P Lee, M J Namkung and T R Hinds
      Drug Metabolism and Disposition December 1996, 24 (12) 1362-1368;

  4. Levy, R H

    1. Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.
      M Bajpai, L K Roskos, D D Shen and R H Levy
      Drug Metabolism and Disposition December 1996, 24 (12) 1401-1403;

  5. Lin, J H

    1. Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.
      J H Lin, M Chiba, I W Chen, J A Nishime and K J Vastag
      Drug Metabolism and Disposition December 1996, 24 (12) 1298-1306;
    2. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
      S K Balani, E J Woolf, V L Hoagland, M G Sturgill, P J Deutsch, K C Yeh and J H Lin
      Drug Metabolism and Disposition December 1996, 24 (12) 1389-1394;

  6. Luffer-Atlas, D

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

  7. Lyszack, E

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

M

  1. Madan, A

    1. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
      A Madan and A Parkinson
      Drug Metabolism and Disposition December 1996, 24 (12) 1307-1313;

  2. Miller, R R

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

  3. Morgan, D J

    1. Conjugation of para-nitrophenol by isolated perfused fetal sheep liver.
      J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J Morgan
      Drug Metabolism and Disposition December 1996, 24 (12) 1378-1384;

N

  1. Namkung, M J

    1. Catalysis of the dealkylation/debenzylation of phenoxazone ethers by hemoglobin in the absence of peroxides: implications for investigations of embryonic biotransformation.
      M R Juchau, D E Chapman, H Y Yang, Q P Lee, M J Namkung and T R Hinds
      Drug Metabolism and Disposition December 1996, 24 (12) 1362-1368;

  2. Nikbakht, K N

    1. Structural characteristics of flavin-containing monooxygenase genes one and two (FMO1 and FMO2).
      M K Wyatt, R M Philpot, G Carver, M P Lawton and K N Nikbakht
      Drug Metabolism and Disposition December 1996, 24 (12) 1320-1327;

  3. Nishime, J A

    1. Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.
      J H Lin, M Chiba, I W Chen, J A Nishime and K J Vastag
      Drug Metabolism and Disposition December 1996, 24 (12) 1298-1306;

O

  1. Ohta, K

    1. Retention mechanism of imidazoles in connective tissue. I. Binding to elastin.
      K Ohta, J I Yamaguchi, M Akimoto, K Fukushima, T Suwa and S Awazu
      Drug Metabolism and Disposition December 1996, 24 (12) 1291-1297;

P

  1. Painter, S K

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

  2. Parkinson, A

    1. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
      A Madan and A Parkinson
      Drug Metabolism and Disposition December 1996, 24 (12) 1307-1313;

  3. Philpot, R M

    1. Structural characteristics of flavin-containing monooxygenase genes one and two (FMO1 and FMO2).
      M K Wyatt, R M Philpot, G Carver, M P Lawton and K N Nikbakht
      Drug Metabolism and Disposition December 1996, 24 (12) 1320-1327;

  4. Poland, A D

    1. Meeting report: receptor-acting xenobiotics and their risk assessment.
      A D Poland
      Drug Metabolism and Disposition December 1996, 24 (12) 1385-1388;

R

  1. Ring, J A

    1. Conjugation of para-nitrophenol by isolated perfused fetal sheep liver.
      J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J Morgan
      Drug Metabolism and Disposition December 1996, 24 (12) 1378-1384;

  2. Rosegay, A

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

  3. Roskos, L K

    1. Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.
      M Bajpai, L K Roskos, D D Shen and R H Levy
      Drug Metabolism and Disposition December 1996, 24 (12) 1401-1403;

S

  1. Schmalix, W A

    1. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines.
      W A Schmalix, D Lang, A Schneider, R Bocker, H Greim and J Doehmer
      Drug Metabolism and Disposition December 1996, 24 (12) 1314-1319;

  2. Schneider, A

    1. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines.
      W A Schmalix, D Lang, A Schneider, R Bocker, H Greim and J Doehmer
      Drug Metabolism and Disposition December 1996, 24 (12) 1314-1319;

  3. Seckel, C S

    1. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.
      R R Abbas, C S Seckel, J K Kidney and J W Fisher
      Drug Metabolism and Disposition December 1996, 24 (12) 1340-1346;

  4. Shen, D D

    1. Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.
      M Bajpai, L K Roskos, D D Shen and R H Levy
      Drug Metabolism and Disposition December 1996, 24 (12) 1401-1403;

  5. Shulkes, A

    1. Conjugation of para-nitrophenol by isolated perfused fetal sheep liver.
      J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J Morgan
      Drug Metabolism and Disposition December 1996, 24 (12) 1378-1384;

  6. Smallwood, R A

    1. Conjugation of para-nitrophenol by isolated perfused fetal sheep liver.
      J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J Morgan
      Drug Metabolism and Disposition December 1996, 24 (12) 1378-1384;

  7. Sowder, R C

    1. Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein P7.
      Y Hathout, D Fabris, M S Han, R C Sowder, L E Henderson and C Fenselau
      Drug Metabolism and Disposition December 1996, 24 (12) 1395-1400;

  8. Sturgill, M G

    1. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
      S K Balani, E J Woolf, V L Hoagland, M G Sturgill, P J Deutsch, K C Yeh and J H Lin
      Drug Metabolism and Disposition December 1996, 24 (12) 1389-1394;

  9. Suwa, T

    1. Retention mechanism of imidazoles in connective tissue. I. Binding to elastin.
      K Ohta, J I Yamaguchi, M Akimoto, K Fukushima, T Suwa and S Awazu
      Drug Metabolism and Disposition December 1996, 24 (12) 1291-1297;

  10. Szumlanski, C

    1. Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation.
      C Her, C Szumlanski, I A Aksoy and R M Weinshilboum
      Drug Metabolism and Disposition December 1996, 24 (12) 1328-1335;

V

  1. Vastag, K J

    1. Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.
      J H Lin, M Chiba, I W Chen, J A Nishime and K J Vastag
      Drug Metabolism and Disposition December 1996, 24 (12) 1298-1306;

  2. Vincent, S H

    1. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
      S H Vincent, S K Painter, P A Krieter, A E Colletti, E Lyszack, A Rosegay, D Dean, D Luffer-Atlas, R R Miller, C Cioffe and S H Chiu
      Drug Metabolism and Disposition December 1996, 24 (12) 1369-1377;

W

  1. Weinshilboum, R M

    1. Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation.
      C Her, C Szumlanski, I A Aksoy and R M Weinshilboum
      Drug Metabolism and Disposition December 1996, 24 (12) 1328-1335;

  2. Woolf, E J

    1. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
      S K Balani, E J Woolf, V L Hoagland, M G Sturgill, P J Deutsch, K C Yeh and J H Lin
      Drug Metabolism and Disposition December 1996, 24 (12) 1389-1394;

  3. Woster, P M

    1. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
      D J Edwards, F H Bellevue and P M Woster
      Drug Metabolism and Disposition December 1996, 24 (12) 1287-1290;

  4. Wyatt, M K

    1. Structural characteristics of flavin-containing monooxygenase genes one and two (FMO1 and FMO2).
      M K Wyatt, R M Philpot, G Carver, M P Lawton and K N Nikbakht
      Drug Metabolism and Disposition December 1996, 24 (12) 1320-1327;

Y

  1. Yamaguchi, J I

    1. Retention mechanism of imidazoles in connective tissue. I. Binding to elastin.
      K Ohta, J I Yamaguchi, M Akimoto, K Fukushima, T Suwa and S Awazu
      Drug Metabolism and Disposition December 1996, 24 (12) 1291-1297;

  2. Yang, H Y

    1. Catalysis of the dealkylation/debenzylation of phenoxazone ethers by hemoglobin in the absence of peroxides: implications for investigations of embryonic biotransformation.
      M R Juchau, D E Chapman, H Y Yang, Q P Lee, M J Namkung and T R Hinds
      Drug Metabolism and Disposition December 1996, 24 (12) 1362-1368;

  3. Yeh, K C

    1. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
      S K Balani, E J Woolf, V L Hoagland, M G Sturgill, P J Deutsch, K C Yeh and J H Lin
      Drug Metabolism and Disposition December 1996, 24 (12) 1389-1394;
Back to top

In this issue

Advertisement